600285.SS · 羚锐制药
China A-shares · RS rating 80 · As of 2026-10-14
| Price | 21.12 CNY |
|---|---|
| 1-day change | +3.9% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 92 / 45 / 65 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 33 / 23 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -9.2% |
| Distance from 52-week high | +10.1% |
| Market cap (USD) | $1.6B |